Successful treatment of lung adenocarcinoma in an 18-year-old man
Primary lung cancer is an extremely rare neoplasm in young adults. We report a case of a primary lung adenocarcinoma in an 18-year-old man who presented for examination of a solitary nodule located in the right lower lobe of the lung. A right lower lobectomy was performed with an incomplete resection because of pleural dissemination (pT4N2M0 stage IIIB adenocarcinoma). Intrathoracic chemotherapy (cisplatin, 50 mg/body) was administered initially, followed by systemic chemotherapy (carboplatin + paclitaxel). A bronchopleural fistula occurred 2 months postoperatively and was successfully treated with conservative therapy, including thoracic drainage, intrathoracic fibrin glue administration, and transbronchial superglue administration. Thereafter, a total of five courses of systemic chemotherapy with minor changes in the administration regimen were performed. The patient was alive and with no evidence of recurrence at his 5-year follow-up.
Key wordsLung adenocarcinoma Young patient Bronchopleural fistula (BPF) Intrathoracic and systemic chemotherapy Superglue
- 1.Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237–245.CrossRefPubMedGoogle Scholar
- 2.Japanese Joint Committee for Lung Cancer Registration. A Japanese lung cancer registry study at 1999. Jpn J Chest Surg 2007;21:108–120.Google Scholar
- 4.Seto T, Ushijima S, Yamamoto H, Ito K, Araki J, Inoue Y, et al. Thoracic Oncology Group. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial. Br J Cancer 2006;95:717–721.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Sugaya M, Sugio K, Nagashima A, Nakanishi R, Sakata H, Nakanishi K, et al. Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer. 2005 ASCO Annual Meeting Proceedings. J Clin Oncol 23:7258.Google Scholar
- 10.The Japan Lung Cancer Society. Evidence-based guidelines for treatment of lung cancer in Japan: 2005 edition. Tokyo: Japan Lung Cancer Society; 2005.Google Scholar